News

The American Heart Association published a report from the Target: AS Registry examining quality metrics for evaluation, surveillance, and management of aortic stenosis patients. The registry aims to establish benchmarks and identify gaps in AS care delivery across participating centers.

Digest: This AHA registry provides standardized quality measures that can guide institutional protocols for AS patient management and inform appropriate timing for intervention referrals.

This clinical reasoning exercise presents a case of slow regular rhythm developing after transcatheter aortic valve replacement (TAVR). The article appears to be an educational case discussion focusing on the differential diagnosis and management of bradycardia post-TAVR.

Digest: Conduction abnormalities requiring pacemaker implantation remain a significant complication of TAVR, affecting clinical outcomes and resource utilization in structural heart programs.

Badano et al published a letter to the editor commenting on a previously published article examining exercise right ventricular-pulmonary arterial coupling as a prognostic marker in primary mitral regurgitation. This correspondence addresses methodological or interpretive aspects of the original research on RV-PA coupling assessment during exercise in mitral regurgitation patients.

Digest: Exercise RV-PA coupling may inform patient selection and timing decisions for transcatheter or surgical mitral valve interventions in primary mitral regurgitation.

This is a correspondence response by Moura-Ferreira et al addressing a previously published article on the prognostic value of exercise right ventricular-pulmonary arterial coupling in primary mitral regurgitation. The response provides commentary or additional perspective on the original research findings regarding RV-PA coupling assessment during exercise in MR patients.

Digest: Exercise RV-PA coupling assessment may refine risk stratification and surgical timing decisions in primary mitral regurgitation patients, particularly those with preserved left ventricular function.

Preclinical study identifies PRMT3-mediated arginine methylation as a mechanism that stabilizes PCSK9 protein, promoting calcification in aortic valve tissue. The findings suggest a novel molecular pathway involving post-translational modification that may contribute to calcific aortic valve disease progression.

Digest: Understanding PCSK9's role in valve calcification could inform future therapeutic strategies to slow or prevent calcific aortic stenosis, potentially reducing the need for surgical or transcatheter valve replacement.

The PRAISE-MR randomized trial evaluated angiotensin receptor neprilysin inhibitor (ARNI) therapy in patients with heart failure with preserved ejection fraction (HFpEF) and secondary mitral regurgitation. The study assessed whether ARNI treatment could reduce mitral regurgitation severity and improve clinical outcomes in this patient population.

Digest: This trial addresses whether medical therapy with ARNI can reduce secondary MR in HFpEF patients, potentially identifying responders who may avoid transcatheter mitral intervention versus non-responders who require TMVR.